Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.

Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Abstract Text:

Ehsan Jabbarzadeh,Tao Jiang,Meng Deng,Lakshmi S Nair,Yusuf M Khan,Cato T Laurencin,Ehsan Jabbarzadeh,Tao Jiang,Meng Deng,Lakshmi S Nair,Yusuf M Khan,Cato T Laurencin,

Bone tissue engineering offers promising alternatives to repair and restore tissues. Our laboratory has employed poly(lactide-co-glycolide) PLAGA microspheres to develop a three dimensional (3-D) porous bioresorbable scaffold with a biomimetic pore structure. Osseous healing and integration with the surrounding tissue depends in part on new blood vessel formation within the porous structure. Since endothelial cells play a key role in angiogenesis (formation of new blood vessels from pre-existing vasculature), the purpose of this study was to better understand human endothelial cell attachment, viability, growth, and phenotypic expression on sintered PLAGA microsphere scaffold. Scanning electron microscopy (SEM) examination showed cells attaching to the surface of microspheres and bridging the pores between the microspheres. Cell proliferation studies indicated that cell number increased during early stages and reached a plateau between days 10 and 14. Immunofluorescent staining for actin showed that cells were proliferating three dimensionally through the scaffolds while staining for PECAM-1 (platelet endothelial cell adhesion molecule) displayed typical localization at cell-cell contacts. Gene expression analysis showed that endothelial cells grown on PLAGA scaffolds maintained their normal characteristic phenotype. The cell proliferation and phenotypic expression were independent of scaffold pore architecture. These results demonstrate that PLAGA sintered microsphere scaffolds can support the growth and biological functions of human endothelial cells. The insights from this study should aid future studies aimed at enhancing angiogenesis in three dimensional tissue engineered scaffolds.

Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Publishing Authors By Initials

E Jabbarzadeh,T Jiang,M Deng,LS Nair,YM Khan,CT Laurencin,E Jabbarzadeh,T Jiang,M Deng,LS Nair,YM Khan,CT Laurencin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Biotechnology and bioengineering

VOLUME: 98

Page Numbers: 1094-102

Journal Abbreviation: Biotechnol. Bioeng.

ISSN: 0006-3592

DAY: 1

MONTH: Dec

YEAR: 2007

Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7502021

Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.

AFFILIATION: Department of Orthopaedic Surgery, University of Virginia, 400 Ray C. Hunt Drive, Suite 330, Charlottesville, Virginia 22903, USA.

Country: United States

AGENCY: United States NIAMS

GRANT: R01-AR052536

ACRONYM: AR

MEDLINETA: Biotechnol Bioeng

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Human endothelial cell growth and phenotypic expression on three dimensional polylactide-co-glycolide sintered microsphere scaffolds for bone tissue engineering Related Publications

• Amorphous hydroxyapatite-sintered polymeric scaffolds for bone tissue regeneration: Physical characterization studies.
• Apatite nano-crystalline surface modification of poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering: implications for protein adsorption.
• Biologically active chitosan systems for tissue engineering and regenerative medicine.
• Biomimetic tissue-engineered anterior cruciate ligament replacement.
• Cato T. Laurencin, MD, PhD.
• Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications.
• Electrospun nanofiber scaffolds: engineering soft tissues.
• Electrospun poly(lactic acid-co-glycolic acid) scaffolds for skin tissue engineering.
• Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.
• Fracture repair with ultrasound: clinical and cell-based evaluation.
• Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.
• In vitro and in vivo evaluation of a novel polymer-ceramic composite scaffold for bone tissue engineering.
• Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach.
• Miscibility and in vitro osteocompatibility of biodegradable blends of poly[(ethyl alanato) (p-phenyl phenoxy) phosphazene] and poly(lactic acid-glycolic acid).
• Nanofibers and nanoparticles for orthopaedic surgery applications.
• Novel low temperature setting nanocrystalline calcium phosphate cements for bone repair: osteoblast cellular response and gene expression studies.
• Novel tubular composite matrix for bone repair.
• Polymers as biomaterials for tissue engineering and controlled drug delivery.
• Polyphosphazene/nano-hydroxyapatite composite microsphere scaffolds for bone tissue engineering.
• Solvent/non-solvent sintering: a novel route to create porous microsphere scaffolds for tissue regeneration.
• Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair.
• Tissue engineering of bone: material and matrix considerations.
• Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix.